Both in Surgical Instruments
Beta Bionics vs SpyGlass Pharma
Over the past year BBNX returned +28.1% and SGP returned +22.1%; their daily moves had a correlation of 0.21.
BBNX +28.1% SGP +22.1%Growth of $1, one year, split-adjusted
| Metric | BBNX | SGP |
|---|---|---|
| Price | $16.75 | $32.24 |
| Market cap | $910.6M | $1.08B |
| Today | −4.72% | −0.83% |
| 1 month | −11.2% | +21.7% |
| 6 months | +62.8% | +34.4% |
| Year to date | −45.0% | — |
| 1 year | −37.5% | — |
| Revenue growth (YoY) | +30.3% | — |
| Gross margin | 57.3% | — |
| Net margin | −68.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.2× | — |
| Net cash | $240.2M | $234.2M |
| Dividend yield | — | — |
| Volatility (60d) | 82.0% | 45.9% |
| Short % of float | 24.4% | 20.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).